Literature DB >> 2866037

Stereospecific opiate binding in living human polymorphonuclear leucocytes.

N E Falke, E G Fischer, R Martin.   

Abstract

Living human polymorphonuclear leucocytes were incubated with various opiate agonists and antagonists in radioreceptor assays. Binding of the opiate antagonists 3H-naloxone and 3H-diprenorphine and of the benzomorphan 3H-ethylketocyclazocine was found at 4 degrees C and at 37 degrees C, 3H-naloxone binding was stereospecific. Binding of the opiate agonist 3H-dihydromorphine was present at 37 degrees C but not at 4 degrees C and had a different time course as compared to the antagonists. At both temperatures no specific binding of the proteolytic stable analogue 3H-D-Ala-D-Leu-enkephalin was found. Autoradiography showed an unspecific accumulation of 3H-naloxone inside the cells and a specific localization of grains at the cell membrane.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2866037     DOI: 10.1016/0309-1651(85)90071-2

Source DB:  PubMed          Journal:  Cell Biol Int Rep        ISSN: 0309-1651


  4 in total

Review 1.  Invertebrate and vertebrate neuroimmune and autoimmunoregulatory commonalties involving opioid peptides.

Authors:  G B Stefano
Journal:  Cell Mol Neurobiol       Date:  1992-10       Impact factor: 5.046

2.  Morphine enhances HIV infection of human blood mononuclear phagocytes through modulation of beta-chemokines and CCR5 receptor.

Authors:  Chang-Jiang Guo; Yuan Li; Sha Tian; Xu Wang; Steven D Douglas; Wen-Zhe Ho
Journal:  J Investig Med       Date:  2002-11       Impact factor: 2.895

Review 3.  Role of the mu-opioid receptor in opioid modulation of immune function.

Authors:  Jana Ninković; Sabita Roy
Journal:  Amino Acids       Date:  2011-12-15       Impact factor: 3.520

4.  Morphine enhances HIV infection of neonatal macrophages.

Authors:  Yuan Li; Jeffrey D Merrill; Kathy Mooney; Li Song; Xu Wang; Chang-Jiang Guo; Rashmin C Savani; David S Metzger; Steven D Douglas; Wen-Zhe Ho
Journal:  Pediatr Res       Date:  2003-05-07       Impact factor: 3.756

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.